Feedback by 6/2/2023: Survey on a new type of targeted medicine called “antibody-drug conjugates” or “ADCs”

[NikoleV]

**Please respond by Friday, June 2.

Have questions about a new type of targeted medicine called “antibody-drug conjugates” or “ADCs”? 

LUNGevity is partnering with PeerView Oncology to host medical education for providers on ADCs. The input from the patient survivor community on this new area of lung cancer care is VERY important to give to providers as part of the medical education. We would LOVE your feedback on this 2 question survey to help us and providers know how much the patient survivor community has heard and where more information is needed. 

https://www.surveymonkey.com/r/SNBFDVS
 

[NikoleV]

Have you ever heard of an ADC or antibody drug conjugate? This is a new style of targeted medicine for people living with lung cancer. We have a 2 question survey to get a sense about what patients and caregivers have heard, if anything, about ADCs.  This survey is for a medical education program for oncologists that we are partnering on with PeerView Oncology. If you have an extra minute, we would LOVE to have your input.

https://www.surveymonkey.com/r/SNBFDVS